✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
In this article, we present a case of dramatic improvement of central fever with recombinant human GH therapy in a patient with posttraumatic GH deficiency
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Growth hormone (GH) deficiency is the most common pituitary hormone deficiency after traumatic brain injury.
📊
Key Findings & Data:Patients with GH deficiency have a reduced sweating capacity which increases the risk of developing hyperthermia.
💡
Conclusion & Impact:In this article, we present a case of dramatic improvement of central fever with recombinant human GH therapy in a patient with posttraumatic GH deficiency
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Growth hormone (GH) deficiency is the most common pituitary hormone deficiency after traumatic brain injury. Patients with GH deficiency have a reduced sweating capacity which increases the risk of developing hyperthermia. To the best of our knowledge, central fever that developed due to GH deficiency and improved with GH treatment has not yet been reported. In this article, we present a case of dramatic improvement of central fever with recombinant human GH therapy in a patient with posttraumatic GH deficiency
🔖
Cite This Article
TUHAN, H. Ü., ANIK, A., ÇATLI, G., ABACI, A., ÖZTÜRK, T., GÜLERYÜZ, H., BÖBER, E. (2015). Recovery of Central Fever after GH Therapy in a Patient with GH Deficiency Secondary to Posttraumatic Brain Injury. Journal of Clinical Research in Pediatric Endocrinology, Cilt: 7 - Sayı: 1, 77–79. https://ajindex.com/articles/270523